News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
Presentation SIF 2017 So, You Want to Implant BVS? Essential Techniques for Simple and Complex Lesions Presenter: David G. Rizik March 10, 2017
News Daily News Length Matters: More Adverse Events With Absorb BVS at 1 Year in Long Lesions L.A. McKeown March 02, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2017 Shelley Wood March 01, 2017
Presentation CTO 2017 BVS in CTOs: Current Experience Presenter: Evald H. Christiansen, Robert W. Yeh, Mauro Carlino February 24, 2017
News Conference News CRT 2017 Absorb BVS: Better Technique, Better Outcomes? More Data—and More Debate Michael O'Riordan February 21, 2017
News Conference News ISET 2017 Bioresorbable Scaffolds for PAD: Does the Strategy Have Legs? Caitlin E. Cox February 17, 2017
News Daily News DESolve Bioresorbable Stent Compares Well With Absorb, but Longer Follow-up Needed Michael O'Riordan February 16, 2017
Presentation JIM 2017 Sudden Left Main Coronary Artery Dissection Following Coronary Angiography of Spontaneous Coronary Artery Dissection Treated with Hybrid DES-BVS Procedure Presenter: Francesco Tomassini February 11, 2017
Presentation JIM 2017 Old and New BVS: Is IVUS/OCT a Must? Presenter: Augusto Pichard February 09, 2017
News Daily News Device, Operator, or Lesion: What Affects Long-term Outcomes With Bioresorbable Scaffolds? Michael O'Riordan February 02, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016